Insulin Lispro vs GLP-1

Head-to-head comparison of Insulin Lispro (Insulin lispro (B28-Lys, B29-Pro human insulin analog)) and GLP-1 (Glucagon-like peptide-1 (7-36 amide)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyInsulin LisproGLP-1
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameInsulin lispro (B28-Lys, B29-Pro human insulin analog)Glucagon-like peptide-1 (7-36 amide)
Molecular Weight5808.0 Da3297 Da
Half-LifeAbout 1 hour1-2 minutes
Amino Acids5130
Typical Dose0.05-0.2 U/kg per mealResearch-only: 0.1-1.0 pmol/kg/min
RouteSubcutaneousIntravenous/Subcutaneous
Purity≥98%≥98%
Studies Count120001200
Research StatusApprovedPre-clinical

Insulin Lispro Benefits

  • Rapid postprandial glucose control
  • Flexible premeal timing
  • Predictable onset of action
  • Useful in basal-bolus regimens

GLP-1 Benefits

  • beta-cell protection
  • improved insulin secretion
  • slower gastric emptying
  • lower postprandial glucose

Insulin Lispro Dosing

Inject SC 0-15 minutes before meals|Adjust dose to carbohydrate intake and premeal glucose|Often paired with a basal insulin

GLP-1 Dosing

0.1-1.0 pmol/kg/min IV infusion in research|0.5-10 nM in vitro|continuous delivery in animal studies

Insulin Lispro Side Effects

  • Hypoglycemia
  • Weight gain
  • Injection-site reactions

GLP-1 Side Effects

  • nausea at pharmacologic exposure
  • tachyphylaxis with continuous exposure
  • headache

Research Overview

Insulin Lispro

Clinical studies show faster onset and shorter duration than regular insulin, improving post-meal glucose control. It is a standard comparator in diabetes pharmacology and closed-loop insulin-delivery research.

GLP-1

Native GLP-1 has a very short half-life because of rapid DPP-4 cleavage, so it is mainly used as a mechanistic research peptide. Across animal and cellular studies it reduces beta-cell apoptosis, improves insulin gene expression, and enhances islet resilience.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Insulin Lispro stacks with:

Insulin GlargineInsulin Degludec

GLP-1 stacks with:

DPP-4 inhibitorsSGLT2 inhibitorsdiet and exercise
rapid-acting insulinprandial controlglucose regulationincretinbeta-cell survivalDPP-4 substrate